PROBANDS: Evaluation in the past one-year at the Breast and Ovarian Cancer Risk Evaluation Clinic (BOCRE) or Cancer Genetics Clinic, both located at the University of Michigan (U-M) Rogel Cancer Center who are positive for hereditary breast and ovarian cancer syndrome (HBOC) (BRCA1, BRCA2) or Lynch Syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM); indeterminate negative; or variants of uncertain clinical significance (VUS). If more than one biological relative is known to have received an evaluation for and or completed germline testing for cancer risk, the relative who was evaluated the longest time ago to align with the tradition definition of a proband as defined by the National Cancer Institute (NCI), i.e., the first person identified as possibility having a genetic disorder and who may receive counseling or testing
PROBANDS: \>= 18-years-old
PROBANDS: Completed genetic testing for hereditary cancer syndromes, regardless of results
PROBANDS: Able to speak and read English
PROBANDS: Access to the internet
PROBANDS: Identifies as African American or Black (may have additional race or ethnicity identities)
RELATIVES: Biological relative of enrolled proband, regardless of testing completion or timing of testing
RELATIVES: \>= 18 years old
RELATIVES: Able to speak and read English
RELATIVES: Access to the internet
You may not be if
PROBANDS: No evaluation at U-M or other facility, or evaluation was more than one year ago, or received an evaluation more recently than the relative
PROBANDS: Under 18-years-old
PROBANDS: Did not receive cancer genetic testing
PROBANDS: Does not speak or read English
PROBANDS: Does not have internet access
PROBANDS: Does not identify as African American or Black
RELATIVES: Not a biological relative of proband
RELATIVES: Under 18-years-old
RELATIVES: Does not speak or read English
RELATIVES: Does not have internet access
Clareo Health | A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families
